14-3-3 promotes sarcolemmal expression of cardiac Ca 1.2 and nucleates isoproterenol-triggered channel super-clustering

Heather C Spooner,Alexandre D Costa,Adriana Hernandez Gonzalez,Husna Ibrahimkhail,Vladimir Yarov-Yarovoy,Mary Horne,Eamonn J Dickson,Rose E Dixon
DOI: https://doi.org/10.1101/2024.08.16.607987
2024-08-19
Abstract:The L-type Ca channel (Ca 1.2) is essential for cardiac excitation-contraction coupling. To contribute to the inward Ca flux that drives Ca -induced-Ca -release, Ca 1.2 channels must be expressed on the sarcolemma; thus the regulatory mechanisms that tune Ca 1.2 expression to meet contractile demand are an emerging area of research. A ubiquitously expressed protein called 14-3-3 has been proposed to affect Ca channel trafficking in non-myocytes, however whether 14-3-3 has similar effects on Ca 1.2 in cardiomyocytes is unknown. 14-3-3 preferentially binds phospho-serine/threonine residues to affect many cellular processes and is known to regulate cardiac ion channels including Na 1.5 and hERG. Altered 14-3-3 expression and function have been implicated in cardiac pathologies including hypertrophy. Accordingly, we tested the hypothesis that 14-3-3 interacts with Ca 1.2 in a phosphorylation-dependent manner and regulates cardiac Ca 1.2 trafficking and recycling. Confocal imaging, proximity ligation assays, super-resolution imaging, and co-immunoprecipitation revealed a population of 14-3-3 colocalized and closely associated with Ca 1.2. The degree of 14-3-3/Ca 1.2 colocalization increased upon stimulation of β-adrenergic receptors with isoproterenol. Notably, only the 14-3-3-associated Ca 1.2 population displayed increased cluster size with isoproterenol, revealing a role for 14-3-3 as a nucleation factor that directs Ca 1.2 super-clustering. 14-3-3 overexpression increased basal Ca 1.2 cluster size and Ca currents in ventricular myocytes, with maintained channel responsivity to isoproterenol. In contrast, isoproterenol-stimulated augmentation of sarcolemmal Ca 1.2 expression and currents in ventricular myocytes were abrogated by 14-3-3 inhibition. These data support a model where 14-3-3 interacts with Ca 1.2 in a phosphorylation-dependent manner to promote enhanced trafficking/recycling, clustering, and activity during β-adrenergic stimulation.
Physiology
What problem does this paper attempt to address?
This paper aims to explore the role of 14 - 3 - 3 proteins in the surface expression, aggregation, and activity regulation of cardiac L - type calcium channels (CaV1.2). Specifically, the researchers focused on whether 14 - 3 - 3 interacts with CaV1.2 in a phosphorylation - dependent manner and further affects the localization, nano - scale distribution of CaV1.2 on the cardiomyocyte membrane, and the super - aggregation phenomenon under β - adrenergic receptor stimulation. ### Research Background L - type calcium channels (CaV1.2) play a crucial role in cardiac excitation - contraction coupling. In order to drive calcium - induced calcium release (CICR), CaV1.2 must be expressed on the cardiomyocyte membrane (i.e., sarcolemma). Therefore, the mechanism for regulating CaV1.2 expression to meet the contraction requirements is an emerging research area. 14 - 3 - 3 is a ubiquitously expressed protein known to affect calcium channel trafficking in non - muscle cells, but its effect on CaV1.2 in cardiomyocytes is unclear. 14 - 3 - 3 affects many cellular processes by preferentially binding to phosphorylated serine/threonine residues and is known to regulate cardiac ion channels such as NaV1.5 and hERG. ### Research Objectives The main objective of the study was to verify whether 14 - 3 - 3 interacts with CaV1.2 in a phosphorylation - dependent manner and regulates the trafficking, recycling, aggregation, and activity of cardiac CaV1.2. In addition, the study also explored the role of 14 - 3 - 3 under β - adrenergic receptor stimulation. ### Main Findings 1. **Interaction between 14 - 3 - 3 and CaV1.2**: - Through co - immunoprecipitation experiments, the researchers found that there is an interaction between 14 - 3 - 3 and CaV1.2 in tsA - 201 cells. - Further experiments showed that this interaction is enhanced under the stimulation of the β - adrenergic receptor agonist isoproterenol. 2. **14 - 3 - 3 promotes the surface expression of CaV1.2**: - Over - expression of 14 - 3 - 3ε significantly increased the surface expression of CaV1.2 and calcium current (ICa). - Using the 14 - 3 - 3 inhibitor difopein reduced the surface expression of CaV1.2 and calcium current. 3. **14 - 3 - 3 enhances the cooperative interaction of CaV1.2**: - Single - channel recordings showed that over - expression of 14 - 3 - 3ε increased the activity of a single CaV1.2 channel, while difopein decreased this activity. - Further analysis indicated that 14 - 3 - 3ε enhanced the cooperativity of CaV1.2 channels, while difopein decreased this cooperativity. 4. **Role of 14 - 3 - 3 under β - adrenergic receptor stimulation**: - Super - resolution imaging and proximity ligation assay (PLA) showed that after isoproterenol stimulation, the co - localization of 14 - 3 - 3 and CaV1.2 on the T - tubule sarcolemma was significantly increased. - Single - molecule localization microscopy (SMLM) experiments further confirmed that isoproterenol stimulation promoted the super - aggregation of CaV1.2 at the sites where 14 - 3 - 3 is present. ### Conclusion The research results support a model in which 14 - 3 - 3 interacts with CaV1.2 in a phosphorylation - dependent manner, promoting its trafficking, recycling, aggregation, and activity on the cardiomyocyte membrane, especially under the condition of β - adrenergic receptor stimulation. These findings are helpful for understanding the regulatory mechanism of cardiac L - type calcium channels and are of great significance for cardiac pathology and treatment.